Pomerantz Law Firm Issues Class Action Alert for Investors in Ardent Health, Inc.
The Pomerantz Law Firm has recently announced the initiation of a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT), signalling a critical juncture for those investors who have suffered financial losses in relation to their investments in the company. This class action centers around allegations of potential securities fraud and other unlawful business practices by Ardent and certain members of its management team. Investors who have acquired Ardent securities during the designated Class Period are encouraged to reach out and seek participation and representation in this significant legal matter.
Key dates for participation are fast approaching, with a deadline set for March 9, 2026, for individuals wishing to become Lead Plaintiff in the case. The firm provides an invitation to contact Danielle Peyton directly via email or telephone for further guidance on how to proceed. It is advised that any inquiries sent through email include essential details such as mailing address, phone number, and the total number of shares purchased.
The backdrop of this lawsuit comes from troubling news released on November 12, 2025, when Ardent disclosed a staggering $43 million decrease in revenue for the third quarter of the fiscal year. This revenue drop was attributed to a reevaluation of accounts receivable collectability following Ardent's adoption of a new revenue accounting system, the Kodiak RCA net revenue platform. This adjustment was outlined as a proactive measure, taking into account 'recently completed hindsight evaluations of previous collection trends.' Introduced as a more dynamic approach, this system enables better recognition of reserve needs earlier in the account lifecycle rather than adhering to the company’s previous 180-day cliff system for reserve acknowledgment.
In conjunction with this disappointing revenue report, Ardent issued a downward revision to its EBITDA guidance for the year 2025, now anticipated to fall to approximately $530 million to $555 million—about 9.6% lower than previously estimated figures, now revised from a range of $575 million to $625 million. The reasons cited for this downturn include ongoing pressures from the overall industry landscape, notably linked to issues surrounding payer denials. Additionally, Ardent reported an increase in professional liability reserves amounting to $54 million, addressing recent settlements and litigation tied to limited claims from 2019 through 2022 in New Mexico, while also factoring in wider industry social inflationary trends.
Following these announcements, Ardent’s stock price saw a dramatic decline, plummeting by $4.75 per share, which represents a significant 33.81% drop, closing at $9.30 per share as of November 13, 2025.
Pomerantz LLP, established as one of the eminent legal firms in the field of corporate, securities, and antitrust class action litigation, holds a storied legacy dating back over 85 years. The firm was founded by Abraham L. Pomerantz, hailed as the dean of the securities class action bar, and continues to advocate for victims of securities fraud, fiduciary breaches, and corporate misconduct. Throughout its history, Pomerantz has successfully recovered substantial damages on behalf of class members affected by corporate malfeasance, reinforcing its commitment to the pursuit of justice and fair treatment for shareholders.
As the case unfolds, affected investors are strongly encouraged to consider joining the class action to seek redress for their losses. Additional details on how to participate are available on the firm’s website, while the law firm remains resolute in its dedication to protecting investor rights in the face of corporate wrongdoing.
Key dates for participation are fast approaching, with a deadline set for March 9, 2026, for individuals wishing to become Lead Plaintiff in the case. The firm provides an invitation to contact Danielle Peyton directly via email or telephone for further guidance on how to proceed. It is advised that any inquiries sent through email include essential details such as mailing address, phone number, and the total number of shares purchased.
The backdrop of this lawsuit comes from troubling news released on November 12, 2025, when Ardent disclosed a staggering $43 million decrease in revenue for the third quarter of the fiscal year. This revenue drop was attributed to a reevaluation of accounts receivable collectability following Ardent's adoption of a new revenue accounting system, the Kodiak RCA net revenue platform. This adjustment was outlined as a proactive measure, taking into account 'recently completed hindsight evaluations of previous collection trends.' Introduced as a more dynamic approach, this system enables better recognition of reserve needs earlier in the account lifecycle rather than adhering to the company’s previous 180-day cliff system for reserve acknowledgment.
In conjunction with this disappointing revenue report, Ardent issued a downward revision to its EBITDA guidance for the year 2025, now anticipated to fall to approximately $530 million to $555 million—about 9.6% lower than previously estimated figures, now revised from a range of $575 million to $625 million. The reasons cited for this downturn include ongoing pressures from the overall industry landscape, notably linked to issues surrounding payer denials. Additionally, Ardent reported an increase in professional liability reserves amounting to $54 million, addressing recent settlements and litigation tied to limited claims from 2019 through 2022 in New Mexico, while also factoring in wider industry social inflationary trends.
Following these announcements, Ardent’s stock price saw a dramatic decline, plummeting by $4.75 per share, which represents a significant 33.81% drop, closing at $9.30 per share as of November 13, 2025.
Pomerantz LLP, established as one of the eminent legal firms in the field of corporate, securities, and antitrust class action litigation, holds a storied legacy dating back over 85 years. The firm was founded by Abraham L. Pomerantz, hailed as the dean of the securities class action bar, and continues to advocate for victims of securities fraud, fiduciary breaches, and corporate misconduct. Throughout its history, Pomerantz has successfully recovered substantial damages on behalf of class members affected by corporate malfeasance, reinforcing its commitment to the pursuit of justice and fair treatment for shareholders.
As the case unfolds, affected investors are strongly encouraged to consider joining the class action to seek redress for their losses. Additional details on how to participate are available on the firm’s website, while the law firm remains resolute in its dedication to protecting investor rights in the face of corporate wrongdoing.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.